We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Blephagel Airless
Uses:
- Poor eyelid and eyelashes hygiene
- Complication of Meibomian Gland dysfunctions (Superficial Punctuate Keratitis)
- Pre and Post-Surgery Prophylaxis
- Palpebral Pathology
- Meibomian Seborrhea
Indications:
Blephagel Airless is an Eyecare product for the daily hygiene of sensitive eyelids. Its formula is suitable for cleansing desquamated and impurity soiled eyelid edges.
Recommended for:
- Contact lens wearers
- Blepharitis (eyelid hygiene)
How to Use:
Apply Blephagel Airless twice a day, morning and before going to sleep, to the skin around the eye, the eye lid and eye lid margins.
Key Benefits:
- Perfume free and non-greasy gel
- Properly cleanses eyelids, mucus and squamae congested eyelash roots
- Refreshes, softens and soothes eyelids without altering the skin's pH balance
- Contains a very mild preservative
Product Information
Blephagel Airless
Uses:
- Poor eyelid and eyelashes hygiene
- Complication of Meibomian Gland dysfunctions (Superficial Punctuate Keratitis)
- Pre and Post-Surgery Prophylaxis
- Palpebral Pathology
- Meibomian Seborrhea
Indications:
Blephagel Airless is an Eyecare product for the daily hygiene of sensitive eyelids. Its formula is suitable for cleansing desquamated and impurity soiled eyelid edges.
Recommended for:
- Contact lens wearers
- Blepharitis (eyelid hygiene)
How to Use:
Apply Blephagel Airless twice a day, morning and before going to sleep, to the skin around the eye, the eye lid and eye lid margins.
Key Benefits:
- Perfume free and non-greasy gel
- Properly cleanses eyelids, mucus and squamae congested eyelash roots
- Refreshes, softens and soothes eyelids without altering the skin's pH balance
- Contains a very mild preservative
-
Offer area
25% Discount New Register User
Code: NewO4PUser-25
-
Offer area
Offer20
Code: Offer20
-
Offer area
Get 20% off all products
Code: Summer20 Valid till:31st August 2025.





